Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up

被引：8
作者：
De Silva, HJ [1 ]
Herath, CA
Sheriff, MHR
机构：
[1] Univ Kelaniya, Dept Med, Fac Med, Ragama, Sri Lanka
[2] Univ Colombo, Fac Med, Dept Clin Med, Colombo, Sri Lanka
来源：
LIVER INTERNATIONAL | 2005年 / 25卷 / 05期
关键词：
D O I：
10.1111/j.1478-3231.2005.01171.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1074 / 1075
页数：2
相关论文
共 5 条
[1]   Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients [J].
Chan, TM ;
Fang, GX ;
Tang, CSO ;
Cheng, IKP ;
Lai, KN ;
Ho, SKN .
HEPATOLOGY, 2002, 36 (05) :1246-1252
[2]  
Fabrizi F, 2002, J NEPHROL, V15, P113
[3]   Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: Meta-analysis of clinical trials [J].
Fabrizi, F ;
Dulai, G ;
Dixit, V ;
Bunnapradist, S ;
Martin, P .
TRANSPLANTATION, 2004, 77 (06) :859-864
[4]   Management of chronic viral hepatitis before and after renal transplantation [J].
Gane, E ;
Pilmore, H .
TRANSPLANTATION, 2002, 74 (04) :427-437
[5]   Effects of long-term lamivudine therapy in renal-transplant patients [J].
Kamar, N ;
Sandres-Saune, K ;
Ribes, D ;
Duffaut, M ;
Selves, J ;
Durand, D ;
Izopet, J ;
Rostaing, L .
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (04) :298-303
1